Climent María Teresa, Serra Anna, Gilabert-Estellés Juan, Gilabert-Aguilar Juan, Llueca Antoni
Department of Obstetrics and Gynecology, University General Hospital of Castellón, 12004 Castellón, Spain.
Department of Medicine, University of Jaume I, 12071 Castellón, Spain.
J Clin Med. 2021 Jun 9;10(12):2553. doi: 10.3390/jcm10122553.
Peritoneal carcinomatosis is a disease's presentation in the advanced stages of many gynecologic tumours. The distribution and volume of the disease are the main factors in achieving complete debulking. Diagnostic laparoscopy is a technique to allow evaluation of the disease. This study's objective is to compare two laparoscopic scores (Fagotti's index and Sugarbaker's peritoneal cancer index (PCI)) and assess the diagnostic accuracy to select patients for neoadjuvant treatment and reduce unnecessary laparotomies.
A non-randomised retrospective cohort study was conducted in patients with peritoneal carcinomatosis (ovarian and endometrial origin) who underwent laparoscopy and subsequent laparotomy. We evaluated the scores' ability to predict incomplete surgery and whether they were related to the patients' prognosis.
We included 34 patients, of which 23.5% received neoadjuvant chemotherapy. The rate of complete cytoreductive surgery was 79.4% ( = 27 patients). The highest sensitivity was obtained with a PCI value greater than 20. It was the best parameter to determine incomplete debulking. Survival curves were analysed according to the "cut off" established for each score, and statically significant differences were found using PCI with respect to Fagotti's Index. However, these differences were not found with Fagotti's score.
The best diagnostic method to classify patients with peritoneal cancer is the PCI. It could be adapted to each surgical team because it allows identifying the "cut off point", which depends on incomplete surgery rate.
腹膜癌是许多妇科肿瘤晚期的一种疾病表现形式。疾病的分布和范围是实现完全减瘤的主要因素。诊断性腹腔镜检查是一种用于评估该疾病的技术。本研究的目的是比较两种腹腔镜评分(法戈蒂指数和苏格贝克腹膜癌指数(PCI)),并评估其诊断准确性,以选择适合新辅助治疗的患者并减少不必要的剖腹手术。
对接受腹腔镜检查及随后剖腹手术的腹膜癌(起源于卵巢和子宫内膜)患者进行了一项非随机回顾性队列研究。我们评估了评分预测手术不完全的能力以及它们是否与患者预后相关。
我们纳入了34例患者,其中23.5%接受了新辅助化疗。完全细胞减灭术的发生率为79.4%(n = 27例患者)。PCI值大于20时敏感性最高。它是确定减瘤不完全的最佳参数。根据为每个评分设定的“临界值”分析生存曲线,发现使用PCI相对于法戈蒂指数存在统计学显著差异。然而,法戈蒂评分未发现这些差异。
对腹膜癌患者进行分类的最佳诊断方法是PCI。它可以根据每个手术团队进行调整,因为它能够确定“临界点”,这取决于手术不完全率。